Effects of different dose schedules of amethopterin on serum and tissue concentrations and urinary excretion patterns.
作者信息
LIGUORI V R, GIGLIO J J, MILLER E, SULLIVAN R D
出版信息
Clin Pharmacol Ther. 1962 Jan-Feb;3:34-40. doi: 10.1002/cpt19623134.
PMID:14465252
Abstract
摘要
相似文献
1
Effects of different dose schedules of amethopterin on serum and tissue concentrations and urinary excretion patterns.不同给药方案的氨甲蝶呤对血清、组织浓度及尿排泄模式的影响。
Clin Pharmacol Ther. 1962 Jan-Feb;3:34-40. doi: 10.1002/cpt19623134.
2
Persistence of amethopterin in normal mouse tissues.氨甲蝶呤在正常小鼠组织中的持久性。
Proc Soc Exp Biol Med. 1953 Jun;83(2):369-73. doi: 10.3181/00379727-83-20362.
3
Distribution of amethopterin in normal mouse tissues following intravenous injection.静脉注射后氨甲蝶呤在正常小鼠组织中的分布。
Proc Soc Exp Biol Med. 1952 Oct;81(1):193-6. doi: 10.3181/00379727-81-19818.
4
Increase of urinary citrovorum factor activity in patients receiving methotrexate (amethopterin).
Proc Soc Exp Biol Med. 1958 Jan;97(1):29-32. doi: 10.3181/00379727-97-23638.
5
Modification of treatment of schedules in the management of advanced mouse leukemia with amethopterin.氨甲蝶呤治疗晚期小鼠白血病时治疗方案的修改
J Natl Cancer Inst. 1956 Aug;17(2):203-12.
6
7
Treatment of bladder cancer with amethopterin.用氨甲蝶呤治疗膀胱癌。
Cancer Chemother Rep. 1962 Jul;20:147.
8
The physiological disposition of dichloromethotrexate-C136 in animals.二氯甲氨蝶呤-C136在动物体内的生理处置
J Pharmacol Exp Ther. 1962 Jul;137:76-83.
9
Studies on the folic acid vitamins. IV. The persistence of amethopterin in mammalian tissues.叶酸维生素的研究。IV. 氨甲蝶呤在哺乳动物组织中的持久性。
Cancer. 1960 Mar-Apr;13:236-40. doi: 10.1002/1097-0142(196003/04)13:2<236::aid-cncr2820130205>3.0.co;2-r.
10
Amethopterin and liver purine metabolism in vivo.氨甲蝶呤与体内肝脏嘌呤代谢
Cancer Res. 1960 Jun;20:620-7.
引用本文的文献
1
Influence of the rate of intravenous administration of eliprodil (SL 82.0715), a new anti-ischaemic agent, on its distribution in rat plasma and tissues.新型抗缺血药物依利罗地（SL 82.0715）静脉给药速率对其在大鼠血浆和组织中分布的影响。
J Pharmacokinet Biopharm. 1995 Apr;23(2):147-61. doi: 10.1007/BF02354269.
2
A critical evaluation of the principles governing the advantages of intra-arterial infusions.对动脉内输注优势相关原则的批判性评估。
J Pharmacokinet Biopharm. 1974 Jun;2(3):257-85. doi: 10.1007/BF01059765.
3
Clinical pharmacokinetics of methotrexate.甲氨蝶呤的临床药代动力学
Clin Pharmacokinet. 1978 Jan-Feb;3(1):1-13. doi: 10.2165/00003088-197803010-00001.
Zotero 插件